Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
DocMorris announces Sfr200m rights issue expected in May -
European capital market participants quite rightly remain unconvinced that the 90 day reprieve is anything to cheer
-
◆ Blistering demand in euros and debut sterling for Australian name ◆ Spread thunders in by 40bp ◆ Doubt that this level of investor demand will continue for others
-
◆ Quick into market after Trump pauses tariffs ◆ Lands close to fair value ◆ Defensive tactics in bookbuilding
-
SSA market most bullish but some in credit, emerging and equity markets still unconvinced anything has changed despite 90 day tariff reprieve
-
Stock drops 17% in highly volatile market
Sub-sections
